 Researchers have gone further and developed inhibitors that do not look like nucleosides, but can still block reverse transcriptase.Another target being considered for HIV antivirals include RNase H—which is a component of reverse transcriptase that splits the synthesized DNA from the original viral RNA.Another target is integrase, which integrate the synthesized DNA into the host cell genome.